Delivery Order SPE2DB20D7066-SPE2DB25FC4BT
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,010,710 units of the pharmaceutical drug Venlafaxine HCL ER 75 mg capsules. The $1,864.74 contract has an ultimate completion date of March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued at up to $999,999,999.00 with DLA through December 31, 2025,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $3,863.66, is for the delivery of 4564936335 - VENLAFAXINE HCL ER 150 MG CAP 90S, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of June 20, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
- This federal contract award, with ID SPE2DX15D3109|SPE2DX24FXVTM, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,728.39 firm fixed-price delivery order is for the supply of 1,000 units of the medication Venlafaxine HCl ER 75 mg capsules. The contract has an ultimate completion date of March 11, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $4,520.21 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4563617987 VENLAFAXINE HCL ER 75 MG CAP 500S. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
- This federal contract award is for the delivery of Venlafaxine HCL ER 37.5 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $5,585.89, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 23, 2024. The contract has a completion date of February 26, 2024 and is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor for this award and does not have any listed...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,162.00 firm fixed-price contract is for the supply of 500 units of Venlafaxine HCL ER 75 MG capsules. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense...
- This federal contract award is for the delivery of venlafaxine hydrochloride extended-release capsules to the Defense Logistics Agency (DLA). The contract, valued at $1,226.88, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 28, 2024. The contract has an ultimate completion date of March 29, 2024 and is a firm fixed-price delivery order. The contract award is not associated with a set-aside designation, indicating open competition. It is part of a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count packages of the prescription medication Venlafaxine HCL ER 150 mg capsules, with a ceiling value of $2,140.72 and a performance period ending on April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,642.56 firm fixed-price delivery order is for the supply of Venlafaxine HCL ER 75 mg capsules to support federal healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award issued by the Department of Defense (DoD) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $7,074.45, is a delivery order for the provision of the prescription medication Venlafaxine HCL ER 225 MG TAB 90S. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4BTDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $3,507.22 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 150mg capsules of the antidepressant medication Venlafaxine HCL ER. The contract has an ultimate completion date of July 17, 2025. AmerisourceBergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and serves as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. This award is not a set-aside contract. AmerisourceBergen Drug Corp also holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which runs through December 2026 and enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 7/16/25 |